Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer

被引:88
作者
Deniaud-Alexandre, E
Touboul, E
Lerouge, D
Grahek, D
Foulquier, JN
Petegnief, Y
Grès, B
El Balaa, H
Keraudy, K
Kerrou, K
Montravers, F
Milleron, B
Lebeau, B
Talbot, JN
机构
[1] Hop Tenon, Serv Oncol Radiotherapie, AP HP, Dept Radiat Oncol, F-75970 Paris, France
[2] Hop Tenon, Dept Nucl Med, AP HP, F-75970 Paris, France
[3] Hop Tenon, Dept Resp Med, AP HP, F-75970 Paris, France
[4] Hop St Antoine, Dept Resp Med, AP HP, F-75571 Paris, France
[5] Univ Paris 06, Paris, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 05期
关键词
non-small-cell lung cancer; three-dimensional conformal radiotherapy; CT; F-18-deoxyglucose-coincidence detection emission tomography (CDET) imaging; image fusion;
D O I
10.1016/j.ijrobp.2005.05.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To report a retrospective study concerning the impact of fused F-18-fluoro-deoxy-D-glucose (FDG)hybrid positron emission tomography (PET) and CT images on three-dimensional conformal radiotherapy planning for patients with non-small-cell lung cancer. Methods and Materials: A total of 101 patients consecutively treated for Stage I-III non-small-cell lung cancer were studied. Each patient underwent CT and FDG-hybrid PET for simulation treatment in the same treatment position. Images were coregistered using five fiducial markers. Target volume delineation was initially performed on the CT images, and the corresponding FDG-PET data were subsequently used as an overlay to the CT data to define the target volume. Results: F-18-fluoro-deoxy-D-glucose-PET identified previously undetected distant metastatic disease in 8 patients, making them ineligible for curative conformal radiotherapy (1 patient presented with some positive uptake corresponding to concomitant pulmonary tuberculosis). Another patient was ineligible for curative treatment because the fused PET-CT images demonstrated excessively extensive intrathoracic disease. The gross tumor volume (GTV) was decreased by CT-PET image fusion in 21 patients (23%) and was increased in 24 patients (26%). The GTV reduction was >= 25% in 7 patients because CT-PET image fusion reduced the pulmonary GTV in 6 patients (3 patients with atelectasis) and the mediastinal nodal GTV in 1 patient. The GTV increase was >= 25% in 14 patients owing to an increase in the pulmonary GTV in 11 patients (4 patients with atelectasis) and detection of occult mediastinal lymph node involvement in 3 patients. Of 81 patients receiving a total dose of; >= 60 Gy at the International Commission on Radiation Units and Measurements point, after CT-PET image fusion, the percentage of total lung volume receiving > 20 Gy increased in 15 cases and decreased in 22. The percentage of total heart volume receiving > 36 Gy increased in 8 patients and decreased in 14. The spinal cord volume receiving at least 45 Gy (2 patients) decreased. Multivariate analysis showed that tumor with atelectasis was the single independent factor that resulted in a significant effect on the modification of the size of the GTV by FDG-PET: tumor with atelectasis (with vs. without atelectasis, p = 0.0001). Conclusion: The results of our study have confirmed that integrated hybrid PET/CT in the treatment position and coregistered images have an impact on treatment planning and management of non-small-cell lung cancer. However, FDG images using dedicated PET scanners and respiration-gated acquisition protocols could improve the PET-CT image coregistration. Furthermore, the impact on treatment outcome remains to be demonstrated. (c) 2005 Elsevier Inc.
引用
收藏
页码:1432 / 1441
页数:10
相关论文
共 45 条
[1]   Improvement of non-small-cell lung cancer staging by means of positron emission tomography [J].
Albes, JM ;
Lietzenmayer, R ;
Schott, U ;
Schülen, E ;
Wehrmann, M ;
Ziemer, G .
THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (01) :42-47
[2]   Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].
Bradley, J ;
Thorstad, WL ;
Mutic, S ;
Miller, TR ;
Dehdashti, F ;
Siegel, BA ;
Bosch, W ;
Bertrand, RJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86
[3]   Evaluation of the solitary pulmonary nodule by positron emission tomography imaging [J].
Bury, T ;
Dowlati, A ;
Paulus, P ;
Corhay, JL ;
Benoit, T ;
Kayembe, JM ;
Limet, R ;
Rigo, P ;
Radermecker, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (03) :410-414
[4]   Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer [J].
Bury, T ;
Dowlati, A ;
Paulus, P ;
Corhay, JL ;
Hustinx, R ;
Ghaye, B ;
Radermecker, M ;
Rigo, P .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (11) :2529-2534
[5]   4D PET/CT - Early observations on integration and impact in radiation therapy planning for lung cancer [J].
Caggiano, AJ ;
Vialotti, C ;
Brunetti, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01) :S290-S290
[6]   Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT:: The impact of 18FDG-hybrid PET fusion [J].
Caldwell, CB ;
Mah, K ;
Ung, YC ;
Danjoux, CE ;
Balogh, JM ;
Ganguli, SN ;
Ehrlich, LE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :923-931
[7]   Molecular (functional) imaging for radiotherapy applications: An RTOG symposium [J].
Chapman, JD ;
Bradley, JD ;
Eary, JF ;
Haubner, R ;
Larson, SM ;
Michalski, JM ;
Okunieff, PG ;
Strauss, HW ;
Ung, YC ;
Welch, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (02) :294-301
[8]   Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):: A feasibility study [J].
Ciernik, IF ;
Dizendorf, E ;
Baumert, BG ;
Reiner, B ;
Burger, C ;
Davis, JB ;
Lütolf, UM ;
Steinert, HC ;
Von Schulthess, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :853-863
[9]   LUNG-TUMOR GROWTH CORRELATES WITH GLUCOSE-METABOLISM MEASURED BY FLUORIDE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY [J].
DUHAYLONGSOD, FG ;
LOWE, VJ ;
PATZ, EF ;
VAUGHN, AL ;
COLEMAN, E ;
WOLFE, WG .
ANNALS OF THORACIC SURGERY, 1995, 60 (05) :1348-1352
[10]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122